CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Anhui Anke Biotechnology (Group) Company., Limited Company Snapshot
Anhui Anke Biotechnology (Group) Company., Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Anhui Anke Biotechnology (Group) Company., Limited with three other companies in this sector in China: Changzhou Qianhong Biopharma Co., Ltd. (2017 sales of 1.07 billion Chinese Renmimbi [US$155.61 million] of which 100% was Bio-pharmaceutical Industry), Tianjin Lisheng Pharmaceutical Company Limited (1.03 billion Chinese Renmimbi [US$150.35 million] of which 100% was Phamaceutical Manufacturing), and Zhejiang Yatai Pharmaceutical Co.,Limited (1.08 billion Chinese Renmimbi [US$158.17 million] of which 57% was CRO Service).

Sales Analysis. During the year ended December of 2017, sales at Anhui Anke Biotechnology (Group) Company., Limited were 1.10 billion Chinese Renmimbi (US$160.11 million). This is an increase of 29.1% versus 2016, when the company's sales were 849.19 million Chinese Renmimbi. This was the fifth consecutive year of sales increases at Anhui Anke Biotechnology (Group) Company., Limited (and since 2012, sales have increased a total of 224%). Sales of Technical Services saw an increase that was more than double the company's growth rate: sales were up 90.6% in 2017, from 23.60 million Chinese Renmimbi to 44.99 million Chinese Renmimbi. Anhui Anke Biotechnology (Group) Company., Limited also saw significant increases in sales in Medicine (up 42.0% to 217.54 million Chinese Renmimbi) and Others (up 74.7% to 20.73 million Chinese Renmimbi) . Not all segments of Anhui Anke Biotechnology (Group) Company., Limited experienced an increase in sales in 2017: sales of Chemical Synthetic Drugs fell 9.3% to 94.92 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Anhui Anke Biotechnology (Group) Company., Limited
  Stock Performance Chart for Anhui Anke Biotechnology (Group) Company., Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (8/10/2018): 16.70
(Figures in Chinese Renmimbi)
1 Week 4.0%   13 Weeks -14.5%  
4 Weeks -18.6%   52 Weeks 41.4%  
 
Anhui Anke Biotechnology (Group) Company., Limited Key Data:
  Ticker: 300009 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 1,096,268,315
(Year Ending Jan 2018).
Employees: 1,657
  Currency: Chinese Renmimbi Market Cap: 16,657,815,155
  Fiscal Yr Ends: December Shares Outstanding: 997,473,961
  Share Type: A Gu Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.